Disease | birth defects |
Phenotype | C0032285|pneumonia |
Sentences | 1 |
PubMedID- 24661413 | While the cost of palivizumab is high, in view of the increased risk of hospitalisation for bronchiolitis and pneumonia in children with birth defects, consideration should be given to offering palivizumab prophylaxis to children with serious birth defects, particularly those with multiple defects. |
Page: 1